Wednesday, October 1, 2014

NuVasive® Demonstrates Expanding EMEA Business at Eurospine 2014 with Surgeon Workshops and Innovative Product Exhibition

SAN DIEGO, CA – October 01, 2014 – NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, today announced that the Company will exhibit its innovative portfolio of spinal products at

FDA Clears Next-Generation SURGIMAP 2.0 Software, First Pre-Operative Planning Platform for Personalized Spinal Implants

NEW YORK--(BUSINESS WIRE)--NEMARIS, Inc. today announced the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the next-generation SURGIMAP 2.0 platform, the preeminent software used to preoperatively plan spine surgery which now offers advanced tools based upon algorithms and the most recent scientific data on the parameters necessary to determine and restore optimal spinal alignment for each patient.

Amedica Corporation Appoints New President and Chief Executive Officer

SALT LAKE CITY, Sept. 30, 2014 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq:AMDA), a commercial biomaterial company focused on using its Silicon Nitride technology platform to develop, manufacture and sell a broad range of medical devices, is pleased to announce

Tuesday, September 30, 2014

Providence Medical Technology Announces Expansion of Patent Portfolio

LAFAYETTE, Calif.--(BUSINESS WIRE)--Providence Medical Technology, Inc. today announced that the U.S. Patent and Trademark Office issued patents 8,834,530, Cervical Distraction Method; 8,834,472, Vertebral Joint Implants and Delivery Tools, and 8,828,062, Vertebral Joint Implants and Delivery Tools to the company in September 2014.

Amedica Corporation Appoints New Vice President of Business Development

SALT LAKE CITY, Sept. 29, 2014 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq:AMDA), a biomaterial company focused on silicon nitride ceramics as a material platform to develop, manufacture and commercialize novel medical devices, is pleased to announce the appointment of Anan Natarajan as Vice President of Business Development, effective immediately.

Monday, September 29, 2014

SIGNUS receives clearance to launch MOBIS® II ST (Structural Titanium) interbody fusion device

Alzenau (Germany) September 29, 2014 – SIGNUS Medizintechnik, the Germany based developer and manufacturer of leading edge spinal implants, announced today that it has received FDA clearance to commercially release its MOBIS® II ST system, which is comprised of a line of

Sunday, September 28, 2014

25 Lateral Lumbar Interbody Fusion Devices.Do you already know the XLIF competitors?

Find the 25 Lateral Lumbar Interbody Fusion Devices in the LLIF page here. Do you already know the XLIF competitors and the Companies that have these  Devices?
Over the last decade, since NuVasive launched the XLIF, more and more products focused on the lateral access have been launched. The lateral approach called XLIF, DLIF or LLIF has been promoted

Saturday, September 27, 2014

Eminent Spine Black Diamondback Rattlesnake™ Lateral Lumbar Plate System

Georgetown, TX, September 26, 2014 --(PR.com)-- Eminent Spine is proud to announce the release of the Black Diamondback Rattlesnake™ lateral lumbar plate system.

Friday, September 26, 2014

Baxano Surgical Completes Financing and Continues Streamlined Business Operations

RALEIGH, N.C., Sep 25, 2014 (GLOBE NEWSWIRE via COMTEX) --Baxano Surgical, Inc. BAXS a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spine, announced that the Company

Spine treatment firm Zyga raises $10 million

September 25, 2014 -(Star Tribune)--Zyga Technology, which makes two devices to treat medical conditions of the lower spine, received $10 million in financing to expand its sales force and pursue three clinical studies.

Thursday, September 25, 2014

RABEA® – Simple and efficient vertebral body fusion for around 20 years

Alzenau, September 25, 2014. Ever since SIGNUS (Alzenau/Germany) obtained CE marketing approval for the cervical fusion cage RABEA® in 1996, more than 100,000 patients worldwide have been successfully treated with it. RABEA® was the first titanium cage to be approved both in Europe and the USA (after FDA approval was granted in 1999), and it is now in use in more than 40 countries.